IT202200008693A1 - Metodo per la preparazione e la purificazione di un agente per il trattamento dell'anemia - Google Patents

Metodo per la preparazione e la purificazione di un agente per il trattamento dell'anemia Download PDF

Info

Publication number
IT202200008693A1
IT202200008693A1 IT102022000008693A IT202200008693A IT202200008693A1 IT 202200008693 A1 IT202200008693 A1 IT 202200008693A1 IT 102022000008693 A IT102022000008693 A IT 102022000008693A IT 202200008693 A IT202200008693 A IT 202200008693A IT 202200008693 A1 IT202200008693 A1 IT 202200008693A1
Authority
IT
Italy
Prior art keywords
anemia
purification
agent
preparation
treatment
Prior art date
Application number
IT102022000008693A
Other languages
English (en)
Inventor
Giuseppina Truglio
Alessandro Restelli
Original Assignee
Dipharma Francis Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma Francis Srl filed Critical Dipharma Francis Srl
Priority to IT102022000008693A priority Critical patent/IT202200008693A1/it
Priority to PCT/EP2022/071427 priority patent/WO2023006986A1/en
Publication of IT202200008693A1 publication Critical patent/IT202200008693A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
IT102022000008693A 2021-07-30 2022-04-29 Metodo per la preparazione e la purificazione di un agente per il trattamento dell'anemia IT202200008693A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102022000008693A IT202200008693A1 (it) 2022-04-29 2022-04-29 Metodo per la preparazione e la purificazione di un agente per il trattamento dell'anemia
PCT/EP2022/071427 WO2023006986A1 (en) 2021-07-30 2022-07-29 Method for preparing and purifying an agent suitable for treating anemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000008693A IT202200008693A1 (it) 2022-04-29 2022-04-29 Metodo per la preparazione e la purificazione di un agente per il trattamento dell'anemia

Publications (1)

Publication Number Publication Date
IT202200008693A1 true IT202200008693A1 (it) 2023-10-29

Family

ID=82308454

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000008693A IT202200008693A1 (it) 2021-07-30 2022-04-29 Metodo per la preparazione e la purificazione di un agente per il trattamento dell'anemia

Country Status (1)

Country Link
IT (1) IT202200008693A1 (it)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007150011A2 (en) * 2006-06-23 2007-12-27 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
WO2018214872A1 (zh) * 2017-05-26 2018-11-29 深圳市塔吉瑞生物医药有限公司 一种取代的嘧啶三酮化合物及包含该化合物的组合物及其用途

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007150011A2 (en) * 2006-06-23 2007-12-27 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
US8324208B2 (en) 2006-06-23 2012-12-04 Glaxosmithkline Llc Prolyl hydroxylase inhibitors
WO2018214872A1 (zh) * 2017-05-26 2018-11-29 深圳市塔吉瑞生物医药有限公司 一种取代的嘧啶三酮化合物及包含该化合物的组合物及其用途

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
O'BRIEN ALEXANDER G. ET AL: "Dehydration of an Insoluble Urea Byproduct Enables the Condensation of DCC and Malonic Acid in Flow", vol. 22, no. 3, 16 March 2018 (2018-03-16), US, pages 399 - 402, XP055855907, ISSN: 1083-6160, Retrieved from the Internet <URL:https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.7b00375> DOI: 10.1021/acs.oprd.7b00375 *
XIA GUOYAO ET AL: "Pyrimidine-2,4,6-trione Derivatives and Their Inhibition of Mutant SOD1-Dependent Protein Aggregation. Toward a Treatment for Amyotrophic Lateral Sclerosis", vol. 54, no. 7, 14 April 2011 (2011-04-14), US, pages 2409 - 2421, XP055855910, ISSN: 0022-2623, Retrieved from the Internet <URL:https://pubs.acs.org/doi/pdf/10.1021/jm101549k> DOI: 10.1021/jm101549k *

Similar Documents

Publication Publication Date Title
ATE417606T1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
FI20012017A (fi) Menetelmä ja laite magneettistimulaation annoslaskentaa varten
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
DE50201306D1 (de) Verfahren zur kontinuierlichen herstellung inhalierfähiger arzneistoffe
DE602004002633D1 (de) Chromfreies Mittel zur Behandlung von Metalloberflächen
DE60234577D1 (de) Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
BRPI0409888A (pt) derivados de pirazol como inibidores de fosfodiesterase 4, composto, composição farmacêutica, método para efetuar a inibição da enzima pde4, incrementar a cognição e/ou tratar a psicose em um paciente, método para o tratamento de um paciente que tem uma doença que envolve nìveis de camp diminuìdos, método para o tratamento de um paciente que sofre de uma doença alérgica ou inflamatória e método para o tratamento de um paciente que sofre de neurodegeneração resultante de uma doença ou de um ferimento
ATE402692T1 (de) Dermale zusammenstellungen die als wirkstoff coenzym q enthalten
FR2862223B1 (fr) Emulsion renfermant des portions de spheres creuses organosiliconees.
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
BR0308957A (pt) Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação
AR054435A1 (es) Agente para profilaxis o terapia contra la depresion o desorden de ansiedad
ATE371454T1 (de) Antagonisten der prostaglandin ep2 und/oder ep4 rezeptoren zur behandlung von menorrhagie
IT202200008693A1 (it) Metodo per la preparazione e la purificazione di un agente per il trattamento dell&#39;anemia
DE60216457D1 (de) Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
MA54379A (fr) Nouvelles formes cristallines d&#39;un inhibiteur mcl-1, procédé de préparation associé et compositions pharmaceutiques les contenant
EA200501802A1 (ru) Сочетание аналептина модафинила и антидепрессанта для лечения депресии
DE60311795D1 (de) Katalytisches verfahren zur herstellung von perfluorethansulfonylfluorid und/oder perfluordiethylsulfon
EP4087860C0 (en) COMPOUNDS AND METHODS FOR TREATING ALZHEIMER&#39;S DISEASE
IT1304374B1 (it) Metodo per il riciclaggio delle polveri derivanti dai processi dilavorazione dell&#39;acciaio o simili mediante la fabbricazione di
FR2828647B1 (fr) Maquillage-soin de la peau pour le traitement et la prevention du vieillissement
ITMI20020693A0 (it) Sostanze composizioni e metodi per il trattamento dell&#39;alopecia androgenetica e dell&#39;ipersecrezione sebacea
ITMI20011284A0 (it) Composizione farmaceutica per il trattamento dell&#39;iperfosfatemia
ITMI20020642A0 (it) Metodo per la colata continua di massa fusa di metallo ed impianto dicolata continua per l&#39;esecuzione del metodo